Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Atrial Natriuretic Peptide (ANP), rat: Benchmarks & Mecha...

    2026-01-31

    Atrial Natriuretic Peptide (ANP), rat: Benchmarks & Mechanisms for Cardiovascular Research

    Executive Summary: Atrial Natriuretic Peptide (ANP), rat is a 28-amino acid peptide hormone with a verified molecular formula of C49H84N20O15S and a molecular weight of 1225.38 g/mol. Synthesized and secreted by atrial myocytes in response to atrial stretch and neurohumoral stimuli, ANP acts as a potent vasodilator and natriuretic agent, directly influencing blood pressure and fluid balance (Zhang et al., 2022). The peptide is highly soluble in DMSO (≥122.5 mg/mL) and water (≥43.5 mg/mL), enabling reproducible dosing in experimental protocols. APExBIO supplies this research-grade peptide (SKU A1009) at 95.92% purity, confirmed by HPLC and mass spectrometry, supporting cardiovascular, renal, and metabolic studies. Its molecular actions and validated applications are distinct from those of adiponectin and other natriuretic peptides.

    Biological Rationale

    Atrial Natriuretic Peptide (ANP), rat is an endogenous peptide hormone secreted by the cardiac atria. It is released in response to atrial distension, increased blood volume, angiotensin II, endothelin, and sympathetic nerve activity. The peptide’s primary function is to reduce blood pressure and volume by promoting natriuresis (sodium excretion), diuresis (water excretion), and vasodilation (APExBIO product page). ANP acts via the natriuretic peptide receptor-A (NPR-A), triggering intracellular cyclic GMP (cGMP) pathways. These effects position ANP as a pivotal regulator of cardiovascular and renal physiology, with translational implications for hypertension and heart failure research. In contrast to adiponectin, which primarily modulates metabolic and inflammatory processes (Zhang et al., 2022), ANP’s actions are acute and hemodynamic.

    For an expanded systems biology perspective on ANP’s integrative roles in blood pressure and adipose tissue metabolism, see Atrial Natriuretic Peptide (ANP), rat: Systems Biology and Translational Insights, which this article updates by detailing recent experimental standards and solubility benchmarks.

    Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

    ANP exerts its physiological effects primarily through binding to NPR-A receptors on target tissues. This interaction activates guanylyl cyclase, increasing intracellular cGMP. Elevated cGMP leads to smooth muscle relaxation (vasodilation), increased glomerular filtration rate (GFR), and reduced sodium reabsorption in renal tubules. Secondary effects include inhibition of renin and aldosterone secretion—further promoting natriuresis and blood pressure reduction (APExBIO). The peptide sequence for rat ANP is H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-OH, which is essential for receptor binding and downstream signaling.

    • ANP action is rapid, with measurable reductions in blood pressure within minutes in vivo after administration (Zhang et al., 2022).
    • ANP is distinct from BNP and CNP in both structure and receptor affinity, making it a specific tool for dissecting natriuretic pathways in rodent models.

    For troubleshooting cell-based assays utilizing ANP, see Optimizing Cell Viability Assays with Atrial Natriuretic Peptide (ANP), rat; this article extends those practical tips with verified molecular specifications and solubility data.

    Evidence & Benchmarks

    • ANP (rat) induces natriuresis and diuresis in rodent models under acute volume expansion conditions (Zhang et al., 2022, DOI).
    • The molecular weight of rat ANP peptide is 1225.38 g/mol, sequence-verified by mass spectrometry and HPLC (APExBIO, product page).
    • Solubility benchmarks: ≥122.5 mg/mL in DMSO; ≥43.5 mg/mL in water; insoluble in ethanol (APExBIO, product page).
    • ANP elicits a significant decrease in plasma aldosterone and renin activity after intravenous administration in rats (Zhang et al., 2022, DOI).
    • ANP’s vasodilatory effect is cGMP-dependent and is abrogated in NPR-A knockout models (see Integrative Roles of ANP for mechanistic contrasts; this article details experimental purity and storage protocols).

    Applications, Limits & Misconceptions

    Applications: ANP is widely used in:

    • Cardiovascular research: Hypertension, heart failure, and vascular homeostasis models.
    • Renal physiology: Studies of glomerular filtration, sodium and water excretion.
    • Adipose tissue metabolism: Investigating the peptide’s role in lipid mobilization and storage.

    For advanced mechanistic and translational research workflows, see Atrial Natriuretic Peptide (ANP), Rat: Expanding Horizons, which this article updates with current purity metrics and validated solubility thresholds for experimental reproducibility.

    Common Pitfalls or Misconceptions

    • ANP is not effective in chronic, non-hypertensive models: Its action is acute and may not address long-term mechanisms of volume overload.
    • Not interchangeable with BNP/CNP: Each natriuretic peptide has distinct receptor affinities and functions.
    • Storage limitations: Reconstituted solutions are unstable for long-term storage; use promptly to ensure bioactivity (store dry at -20°C).
    • Insolubility in ethanol: Attempting to dissolve ANP in ethanol leads to precipitation and assay failure.
    • Species selectivity: Rat ANP sequence differs from human; use species-matched reagents for in vivo work.

    Workflow Integration & Parameters

    APExBIO’s Atrial Natriuretic Peptide (ANP), rat (SKU A1009) is supplied as a lyophilized solid with a purity of 95.92% (HPLC/mass spectrometry-verified). The peptide should be stored at -20°C in its dry form. For experimental use, dissolve at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water; avoid ethanol. Prepare aliquots to prevent repeated freeze-thaw cycles. Use solutions promptly to maintain integrity. For cardiovascular and renal assays, dosing and timing should be optimized according to animal model and outcome measures. Refer to the Atrial Natriuretic Peptide (ANP), rat product page for lot-specific analysis certificates.

    For precision cardiovascular research and troubleshooting, see Atrial Natriuretic Peptide: Precision Cardiovascular Research. This article provides updated solubility and storage benchmarks.

    Conclusion & Outlook

    Atrial Natriuretic Peptide (ANP), rat remains a critical reagent for dissecting blood pressure and fluid homeostasis in preclinical research. Its well-characterized sequence, solubility, and purity profiles—when sourced from APExBIO—ensure reproducibility and reliability in cardiovascular and renal studies. Ongoing research is expanding the understanding of ANP’s roles in metabolic regulation and its translational relevance for human disease models. Researchers should employ validated protocols and species-appropriate reagents for robust results.